CINCINNATI, July 18, 2019 /PRNewswire/ -- Home Helpers® Home Care, a leading network of in-home Caregiving providers, will commemorate National Hire a Veteran Day this

Secures Two-Year Contract to Continue to Supply Italy with high-quality medical cannabis  NYSE: ACB  TSX:ACB  EDMONTON, July 18, 2019 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today that th

SEATTLE, July 18, 2019 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) ("CTI" or "the Company") today announced the outcome of a Type B, End-of-Phase-2a meeting with the U.S. Food and Drug Administration ("FDA" or "the Agency") for the continued development of its investigational myelofibrosis treatment candidate, pacritinib. Following this meeting, CTI plans to

LITTLE ROCK, Ark., July 18, 2019 /PRNewswire/ -- Delta Dental of Arkansas, the largest provider of dental benefits in the state, has again been named one of the Best Places to Work in Arkansas. The seventh annual program, created by Arkansas Business and Best Companies Group, was designed to id

FRANKLIN LAKES, N.J., July 18, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls related to certain Alaris™ Pump Modules Model 8100 manufactured between April 2011 and June 2017 and certai

STAINES-UPON-THAMES, United Kingdom and LONDON, July 18, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceut

STAINES-UPON-THAMES, United Kingdom and LONDON, July 18, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, and Silence Therapeutics plc (LON: SLN), a leader in the discovery, development and delivery of novel RNA2 interference (RNAi) therapeutics for the treatment of serious diseases, today

WHIPPANY, N.J. and PRINCETON, N.J. and OSAKA, Japan, July 18, 2019 /PRNewswire/ -- Bayer, Bristol-Myers Squibb Company (NYSE: BMY) and Ono Pharmaceutical Co., Ltd. ("Ono") announced today the three companies have entered into a clinical collaboration agreement to evaluate the combination of Bayer's kinase inhibitor Stivarga

Proceeds will be used, in part, to fund the cash portion of the initial consideration for the SugarLeaf acquisition Significant participation by Neptune's directors and management as well as Neptune's largest shareholder, Perceptive Advisors LAVAL, QC, July 18, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the

CLEVELAND, July 18, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second quarter 2019 financial results.